Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Spain
Clinical trial register · Spain

Clinical Trials in Spain

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5909 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
5909
Studies in scope
all four open statuses
3100
Recruiting now
open to new participants
1129
Lead sponsors
across recruiting studies
Top sites
Madrid 63 Barcelona 57 Valencia 30 Seville 29 Málaga 27

Trials in this register

79 of 5909 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Santander, Santiago de Compostela, Barcelona, Coslada, Madrid, Málaga, Oviedo
2026-12-16
Not yet open
Bristol-Myers Squibb
Phase 2
80
Majadahonda, Barcelona, Málaga
2026-11-30
Recruiting
Bristol-Myers Squibb
Phase 1/2
84
A Coruña, Córdoba
2026-10-06
Recruiting
Bristol-Myers Squibb
Phase 3
176
Barcelona, Madrid
2026-10-06
Recruiting
Bristol-Myers Squibb
Phase 2
160
Badalona, Seville, Barcelona, Madrid, Majadahonda, Málaga
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Majadahonda, Seville, A Coruña, Jaén, Jerez de la Frontera, Madrid, Málaga, Valencia
2026-09-08
Active, closed
Bristol-Myers Squibb
Observational
1,200
Madrid
2026-07-15
Recruiting
Bristol-Myers Squibb
Phase 3
850
L'Hospitalet Del Llobregat, Barcelona, Madrid, Valencia, Barakaldo, Málaga, Seville, Zaragoza
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Barcelona, Santander, Pamplona, Valencia, Madrid, Málaga
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Barcelona, Barakaldo, Jaén, Madrid, Málaga, Murcia
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 1/2
240
Madrid
2026-02-03
Active, closed
Bristol-Myers Squibb
Observational
1,300
Madrid
2026-02-02
Recruiting
Bristol-Myers Squibb
Phase 1
281
Córdoba, Barcelona
2026-01-15
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Barcelona, Hospitalet, Madrid, Majadahonda, Málaga, Seville, Valencia
2026-01-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Santiago de Compostela, Barcelona, Madrid, Pamplona, Badalona, Elche, Málaga, Salamanca
2025-12-31
Recruiting
Bristol-Myers Squibb
Phase 3
366
Esplugues de Llobregat, Barcelona, Madrid, Santiago de Compostela
2025-12-03
Recruiting
Bristol-Myers Squibb
Phase 3
650
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-12-02
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
NCT07223047Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
Bristol-Myers Squibb
Phase 1/2
252
Badalona, Hortaleza
2025-11-25
Recruiting
Bristol-Myers Squibb
Phase 2/3
661
Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia, Zaragoza
2025-11-05
Recruiting
Bristol-Myers Squibb
Phase 1/2
540
Málaga, Badalona, Barcelona, Pamplona, Madrid
2025-10-15
Recruiting
Bristol-Myers Squibb
Observational
223
Mérida, Barcelona
2025-10-08
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Barcelona, Santander, Madrid, Valencia, Badajoz, Córdoba, Seville
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Badalona, Barcelona, Las Palmas de Gran Canaria, Alcorcón, Málaga, Salamanca, Seville, Madrid
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
A Coruña, Elche, Barcelona, Hospitalet, Donostia / San Sebastian, Madrid, Málaga, Valencia
2025-09-11
Recruiting
Bristol-Myers Squibb
Phase 3
586
Barcelona, Donostia / San Sebastian, Santander, Pozuelo de Alarcón, Valencia, Madrid
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
450
Barcelona, Bilbao
2025-07-18
Recruiting
Bristol-Myers Squibb
Phase 3
586
Seville, Sant Cugat del Vallès, Barcelona, Lleida, Pamplona, Madrid
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
426
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-07-10
Recruiting
Bristol-Myers Squibb
Phase 3
274
Barcelona, Bilbao
2025-06-13
Recruiting
Bristol-Myers Squibb
Phase 3
194
Esplugues de Llobregat, Vigo, Seville, Valencia, Zaragoza
2025-04-08
Recruiting
Bristol-Myers Squibb
Phase 3
60
Barcelona, Madrid, Valencia
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 1/2
286
Barcelona, Pamplona, Madrid
2025-02-17
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Santiago de Compostela, Barcelona, Hospitalet, Madrid, Majadahonda, Valencia, Málaga, Seville
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
A Coruña, Barcelona, L'Hospitalet de Llobregat, Palma, Madrid, Majadahonda, Valencia, Málaga
2024-10-07
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
NCT06476808High-grade Serous Ovarian Carcinoma (HGSOC), Uterine Serous Carcinoma (USC), Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 1
240
Barcelona, Avda.Pio XII 36,
2024-09-06
Active, closed
Bristol-Myers Squibb
Phase 3
44
Barcelona, Madrid
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 2
310
Barcelona, Sant Cugat del Vallès, Lleida
2024-03-20
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Málaga, Barcelona, Madrid, Pamplona, Salamanca
2023-12-29
Active, closed
Bristol-Myers Squibb
Phase 3
190
A Coruña, Santiago de Compostela, Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 2
227
L'Hospitalet de Llobregat, Majadahonda, El Palmar, Madrid, Málaga, Seville, Valencia
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
100
Barcelona, Cartagena, Badalona, Cantabria, San Pedro Alcántara, Málaga, Seville
2023-11-06
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Badalona, Barcelona, Santander, Santiago de Compostela, Málaga, Madrid, Majadahonda, Oviedo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Barcelona, L'Hospitalet de Llobregat, Valencia, Granada, Madrid, Oviedo, Salamanca, Seville
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
106
L'Hospitalet de Llobregat, Barcelona, Granada, Madrid, Ourense, Salamanca, Valencia
2023-10-05
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Santander, Santiago de Compostela, Madrid, Majadahonda, Barcelona, Girona, Oviedo, Pamplona
2023-09-14
Active, closed
Bristol-Myers Squibb
Phase 3
774
Mérida, Santander, San Cristóbal de La Laguna, A Coruña, Santiago de Compostela, Seville
2023-09-11
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Barcelona, Cáceres, Las Palmas de Gran Canaria, Murcia, Oviedo, Valencia, Badalona, Madrid
2023-06-22
Active, closed
Bristol-Myers Squibb
Observational
200
Barcelona
2023-06-14
Active, closed
Bristol-Myers Squibb
Phase 1/2
100
Málaga, Badalona, Pamplona, Madrid
2023-06-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
A Coruña, Barcelona, Donostia / San Sebastian, Jaén, Madrid, Valencia, Badalona, Las Palmas de Gran Canaria
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
513
Mérida, Barcelona, Bilbao, Santander, Cordoba, Seville, Valencia, Valladolid
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
606
Badalona, Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, San Cristóbal de La Laguna, Valencia, Granada
2023-01-10
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
120
Badalona, Esplugues de Llobregat, Madrid
2022-05-30
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
Bristol-Myers Squibb
Phase 1/2
1,109
Málaga, Badalona, Barcelona, Madrid, Pamplona
2021-05-27
Active, closed
Bristol-Myers Squibb
Phase 3
681
Barcelona, Madrid, Sabadell, Santander, Seville
2021-05-21
Recruiting
Bristol-Myers Squibb
Phase 3
153
Alicante, Barakaldo, Esplugues de Llobregat, Las Palmas de GC, Madrid
2021-03-23
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Badalona, Santander, Madrid, Salamanca, Valencia
2021-03-22
Active, closed
Bristol-Myers Squibb
Phase 3
790
Barcelona, A Coruña, Badalona, Madrid, Málaga, Santander, Valencia
2019-10-28
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Donostia / San Sebastian, Majadahonda, Pamplona, A Coruña, Alicante, Badalona, Barcelona, Burgos
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
437
Barcelona, Córdoba, Madrid, Pamplona, Sabadell, Santander, Santiago Compostela, Seville
2019-06-21
Active, closed
Bristol-Myers Squibb
Phase 3
545
Barcelona, Córdoba, Donostia / San Sebastian, Madrid, Pamplona, Sabadell (Barcelona), Seville, Valencia
2018-04-18
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
A Coruña, Barcelona, Madrid, San Sabastian Gipuzkoa, Seville
2018-04-11
Active, closed
Bristol-Myers Squibb
Observational
800
Sant Joan Despí, Barcelona, Madrid, Murcia, Valencia
2013-01-30
Rows per page Showing 1–79 of 79
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-spain

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 79 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Spain?

45 of the 79 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 32 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 79 studies
PhaseStudiesRecruitingShare
Phase 3391849.4%
Phase 1/2131116.5%
Phase 2/310712.7%
Phase 28410.1%
Observational627.6%
Phase 1333.8%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb7945

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Melanoma (4) Plaque Psoriasis (3) Non-small Cell Lung Cancer (NSCLC) (3) Carcinoma, Non-Small-Cell Lung (3) Myelodysplastic Syndromes (3) Multiple Myeloma (2) Advanced Solid Tumors (2) Alzheimer's Disease (2) Alzheimer Disease (2) Psoriatic Arthritis (2) Non-Small Cell Lung Cancer (2) Renal Cell Carcinoma (2) Untreated, Unresectable, or Metastatic Colorectal Cancer (1) Obstructive Hypertrophic Cardiomyopathy (1) Pancreatic Ductal Adenocarcinoma (1)
→

Browse trials by site location

Madrid (63) Barcelona (57) Valencia (30) Seville (29) Málaga (27) Badalona (17) Pamplona (15) Majadahonda (15) Santander (15) A Coruña (13) Santiago de Compostela (9) Salamanca (9) Oviedo (7) Córdoba (6) Donostia / San Sebastian (5)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.